Helping to Bring Improved and Novel Therapies to the Right Patient Population Faster

Access Cancer Cell
Line Proliferation Assays to
Identify Predictive Drug
Response Biomarkers

ONCOLINES®

Apply Combination Studies
to Identify
Novel Synergies

SYNERGYFINDER

Use Cell-Based Assays
to Determine
Mechanism of Action

MECHANISTIC
CELL BIOLOGY

New bioinformatics service

Oncolines launches ProteomicsProfiler Figure (A) Scatterplots of basal gene and protein expression levels for EGFR (left, strongly [...]

Premium Benefits of Oncolines Precision Medicine Services: Cell-Based Assays, Drug Combinations, High-Throughput Screening

  • Integration of cancer biology and big data analysis

  • Identification of patient selection markers

  • Side-by-side comparison with known anti-cancer agents

  • Discovery of targeted and novel synergistic drug combinations

  • Science-driven technology platforms

  • Short turnaround times

How may we help you?